Inventiva S.A. (IVA) stock
IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
$3.68−0.20 (-5.15%)
Close on Nov 13, 2026Market cap $711.11MP/E –Yield –
Inventiva EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -1.90 EUR. The highest annual figure on record is -0.99 EUR in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1.90 EUR | – |
| FY2024 | Dec 31, 2024 | -3.08 EUR | – |
| FY2023 | Dec 31, 2023 | -2.43 EUR | – |
| FY2022 | Dec 31, 2022 | -1.31 EUR | – |
| FY2021 | Dec 31, 2021 | -1.27 EUR | – |
| FY2020 | Dec 31, 2020 | -0.99 EUR | – |
| FY2019 | Dec 31, 2019 | -1.28 EUR | – |
| FY2018 | Dec 31, 2018 | -1.61 EUR | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?